The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)
 

Mauricio Tohen

Lilly Corporate Center

Indianapolis

IN 46285

United States

[email]@lilly.com

Name/email consistency: high

 
 
 
 
 
 
 

Affiliation

  • Lilly Corporate Center, Indianapolis, IN 46285, United States. 2000 - 2009

References

  1. Maintenance of response following stabilization of mixed index episodes with olanzapine monotherapy in a randomized, double-blind, placebo-controlled study of bipolar 1 disorder. Tohen, M., Sutton, V.K., Calabrese, J.R., Sachs, G.S., Bowden, C.L. J. Affect. Disord (2009) [Pubmed]
  2. Olanzapine plus carbamazepine v. carbamazepine alone in treating manic episodes. Tohen, M., Bowden, C.L., Smulevich, A.B., Bergstrom, R., Quinlan, T., Osuntokun, O., Wang, W.V., Oliff, H.S., Martenyi, F., Kryzhanovskaya, L.A., Greil, W. Br. J. Psychiatry (2008) [Pubmed]
  3. Olanzapine versus divalproex versus placebo in the treatment of mild to moderate mania: a randomized, 12-week, double-blind study. Tohen, M., Vieta, E., Goodwin, G.M., Sun, B., Amsterdam, J.D., Banov, M., Shekhar, A., Aaronson, S.T., Bardenstein, L., Grecu-Gabos, I., Tochilov, V., Prelipceanu, D., Oliff, H.S., Kryzhanovskaya, L., Bowden, C. J. Clin. Psychiatry (2008) [Pubmed]
  4. Clinical trials in bipolar mania: implications in study design and drug development. Tohen, M. Arch. Gen. Psychiatry (2008) [Pubmed]
  5. Olanzapine versus placebo in the treatment of adolescents with bipolar mania. Tohen, M., Kryzhanovskaya, L., Carlson, G., Delbello, M., Wozniak, J., Kowatch, R., Wagner, K., Findling, R., Lin, D., Robertson-Plouch, C., Xu, W., Dittmann, R.W., Biederman, J. Am. J. Psychiatry (2007) [Pubmed]
  6. Effect of comorbid anxiety on treatment response in bipolar depression. Tohen, M., Calabrese, J., Vieta, E., Bowden, C., Gonzalez-Pinto, A., Lin, D., Xu, W., Corya, S. J. Affect. Disord (2007) [Pubmed]
  7. Randomized, placebo-controlled trial of olanzapine as maintenance therapy in patients with bipolar I disorder responding to acute treatment with olanzapine. Tohen, M., Calabrese, J.R., Sachs, G.S., Banov, M.D., Detke, H.C., Risser, R., Baker, R.W., Chou, J.C., Bowden, C.L. Am. J. Psychiatry (2006) [Pubmed]
  8. Influence of sub-syndromal symptoms after remission from manic or mixed episodes. Tohen, M., Bowden, C.L., Calabrese, J.R., Lin, D., Forrester, T.D., Sachs, G.S., Koukopoulos, A., Yatham, L., Grunze, H. Br. J. Psychiatry (2006) [Pubmed]
  9. Olanzapine versus lithium in the maintenance treatment of bipolar disorder: a 12-month, randomized, double-blind, controlled clinical trial. Tohen, M., Greil, W., Calabrese, J.R., Sachs, G.S., Yatham, L.N., Oerlinghausen, B.M., Koukopoulos, A., Cassano, G.B., Grunze, H., Licht, R.W., Dell'Osso, L., Evans, A.R., Risser, R., Baker, R.W., Crane, H., Dossenbach, M.R., Bowden, C.L. Am. J. Psychiatry (2005) [Pubmed]
  10. Relapse prevention in bipolar I disorder: 18-month comparison of olanzapine plus mood stabiliser v. mood stabiliser alone. Tohen, M., Chengappa, K.N., Suppes, T., Baker, R.W., Zarate, C.A., Bowden, C.L., Sachs, G.S., Kupfer, D.J., Ghaemi, S.N., Feldman, P.D., Risser, R.C., Evans, A.R., Calabrese, J.R. Br. J. Psychiatry (2004) [Pubmed]
  11. Olanzapine versus divalproex sodium for the treatment of acute mania and maintenance of remission: a 47-week study. Tohen, M., Ketter, T.A., Zarate, C.A., Suppes, T., Frye, M., Altshuler, L., Zajecka, J., Schuh, L.M., Risser, R.C., Brown, E., Baker, R.W. Am. J. Psychiatry (2003) [Pubmed]
  12. Efficacy of olanzapine and olanzapine-fluoxetine combination in the treatment of bipolar I depression. Tohen, M., Vieta, E., Calabrese, J., Ketter, T.A., Sachs, G., Bowden, C., Mitchell, P.B., Centorrino, F., Risser, R., Baker, R.W., Evans, A.R., Beymer, K., Dube, S., Tollefson, G.D., Breier, A. Arch. Gen. Psychiatry (2003) [Pubmed]
  13. The McLean-Harvard First-Episode Mania Study: prediction of recovery and first recurrence. Tohen, M., Zarate, C.A., Hennen, J., Khalsa, H.M., Strakowski, S.M., Gebre-Medhin, P., Salvatore, P., Baldessarini, R.J. Am. J. Psychiatry (2003) [Pubmed]
  14. A 12-week, double-blind comparison of olanzapine vs haloperidol in the treatment of acute mania. Tohen, M., Goldberg, J.F., Gonzalez-Pinto Arrillaga, A.M., Azorin, J.M., Vieta, E., Hardy-Bayle, M.C., Lawson, W.B., Emsley, R.A., Zhang, F., Baker, R.W., Risser, R.C., Namjoshi, M.A., Evans, A.R., Breier, A. Arch. Gen. Psychiatry (2003) [Pubmed]
  15. Olanzapine versus divalproex in the treatment of acute mania. Tohen, M., Baker, R.W., Altshuler, L.L., Zarate, C.A., Suppes, T., Ketter, T.A., Milton, D.R., Risser, R., Gilmore, J.A., Breier, A., Tollefson, G.A. Am. J. Psychiatry (2002) [Pubmed]
  16. Olanzapine versus haloperidol in schizoaffective disorder, bipolar type. Tohen, M., Zhang, F., Keck, P.E., Feldman, P.D., Risser, R.C., Tran, P.V., Breier, A. J. Affect. Disord (2001) [Pubmed]
  17. Efficacy of olanzapine in acute bipolar mania: a double-blind, placebo-controlled study. The Olanzipine HGGW Study Group. Tohen, M., Jacobs, T.G., Grundy, S.L., McElroy, S.L., Banov, M.C., Janicak, P.G., Sanger, T., Risser, R., Zhang, F., Toma, V., Francis, J., Tollefson, G.D., Breier, A. Arch. Gen. Psychiatry (2000) [Pubmed]
  18. Onset of action of antipsychotics in the treatment of mania. Tohen, M., Jacobs, T.G., Feldman, P.D. Bipolar. Disord (2000) [Pubmed]
 
WikiGenes - Universities